Liquid blood test to help detect kidney cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a “liquid biopsy” blood test can help detect kidney cancer when a CT scan looks suspicious but does not show cancer. It may help avoid unnecessary procedures or catch cancer patterns earlier, but it will depend on the type of kidney tumor and your situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a CT scan because kidney cancer was suspected, but the scan did not show kidney cancer
- If you have clear cell kidney cancer or oncocytoma, your diagnosis must be confirmed by a biopsy or surgical tissue sample
- You can sign an informed consent form
- You are able to complete the study procedures as planned
- You likely need to be able to give blood samples for the liquid biopsy test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.
This study looks for “biomarkers,” which are measurable signs (often from blood or tissue), to better understand kidney cancer. It may help doctors identify who has kidney cancer and how it behaves.
This study uses a simple blood test (liquid biopsy) to find early signs of lung cancer in people who are at risk. It aims to catch lung cancer earlier, when it may be easier to treat.
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
This study tests whether a liquid biopsy (a simple blood test) can help monitor germ cell tumors (a type of testicular cancer) that have spread or have a high risk of coming back. It may help guide treatment decisions without needing repeated tissue biopsies.
This study follows people with newly diagnosed kidney cancer who have not started treatment. It tests whether a special blood test can monitor the cancer over time, alongside standard follow-up after planned surgery.
Hear when a new Renal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.